Data coverage, completeness and provenance for INOVIQ LTD in the Stock Market API — Health Care · Diagnostics & Research.
Source date: 2026-10-29T23:54:47. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.1350 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.1350 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.1375 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.1400 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.1400 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/IIQ/prices · Price parameters and adjustment semantics
INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an immunoaffinity magnetic bead-based isolation system for exosome isolation from plasma, serum, urine, saliva and cell-conditioned medium. It also offers non-invasive diagnostics using its proprietary exosome development technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.
Website: https://www.inoviq.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/IIQ/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 30 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 30 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 30 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 29 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/IIQ
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/IIQ/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/IIQ/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/IIQ/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/IIQ/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/IIQ
Free tier — instant API key. Built for AI agents.